AstraZeneca aims for US billion in total revenue by 2030

AstraZeneca aims for US$80 billion in total revenue by 2030

May 21, 2024 / Riah Marton /



ASTRAZENECA aims to grow revenue by about 75 per cent to US$80 billion by 2030, it said on Tuesday (May 21), boosted by the expected launch of 20 new medicines and through growth in its existing oncology, biopharmaceuticals and rare disease portfolio.

Posted in

Riah Marton

I'm Riah Marton, a dynamic journalist for Forbes40under40. I specialize in profiling emerging leaders and innovators, bringing their stories to life with compelling storytelling and keen analysis. I am dedicated to spotlighting tomorrow's influential figures.

Leave a Comment